Phytoestrogens: endocrine disrupters or replacement for hormone replacement therapy? (Q35074555)

6 August 2017

1 reference

title

Phytoestrogens: endocrine disrupters or replacement for hormone replacement therapy? (English)

1 reference

6 August 2017

Wolfgang Wuttke

1

1 reference

6 August 2017

Hubertus Jarry

2

1 reference

6 August 2017

Tamara Becker

3

1 reference

6 August 2017

Alexander Schultens

4

1 reference

6 August 2017

Volker Christoffel

5

1 reference

6 August 2017

Christoph Gorkow

6

1 reference

6 August 2017

Dana Seidlová-Wuttke

7

1 reference

6 August 2017

1 March 2003

1 reference

6 August 2017

1 reference

6 August 2017

44 Suppl 1

1 reference

6 August 2017

S9-20

1 reference

Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Postmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and meta-analysis for the U.S. Preventive Services Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

The past, present, and future of selective estrogen receptor modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Selective estrogen receptor modulators as a new therapeutic drug group: concept to reality in a decade

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Soybean isoflavones as an alternative to traditional hormone replacement therapy: are we there yet?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Hormonal effects of soy isoflavones: studies in premenopausal and postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Physiological investigation of a unique extract of black cohosh (Cimicifugae racemosae rhizoma): a 6-month clinical study demonstrates no systemic estrogenic effect

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Selective estrogen receptor modulators and phytoestrogens: new therapies for the postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disease in normal postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Treatment of urogenital atrophy with low-dose estradiol: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Urogenital aging--a hidden problem

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Menopausal genuine stress urinary incontinence treated with conjugated estrogens plus progestogens

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

The effect of oestrogen supplementation on post-menopausal urinary stress incontinence: a double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Differential expression of estrogen receptors α and β in adult rat accessory sex glands and lower urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Cellular proliferation in the female lower urinary tract with reference to oestrogen status

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Estrogens and lipids. Can HRT designer estrogens, and phytoestrogens reduce cardiovascular risk markers after menopause?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Soy, soy phytoestrogens and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Estrogens in the causation of breast, endometrial and ovarian cancers - evidence and hypotheses from epidemiological findings

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Windows in early mammary development: critical or not?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Preventive effects of isoflavones, genistein and daidzein, on estradiol-17beta-related endometrial carcinogenesis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Protection against breast cancer with genistein: a component of soy.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Nipple aspirate fluid in epidemiologic studies of breast disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Molecular effects of genistein on estrogen receptor mediated pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Antiestrogenic activities of Cimicifuga racemosa extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Hormone replacement therapy and the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Phytoestrogens and carcinogenesis-differential effects of genistein in experimental models of normal and malignant rat endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Trifolium pratense (red clover) exhibits estrogenic effects in vivo in ovariectomized Sprague-Dawley rats

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Phytoestrogen supplementation and endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Cimicifuga and Melbrosia lack oestrogenic effects in mice and rats

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Postmenopausal hot flushes: a disorder of thermoregulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Further evidence that preoptic anterior hypothalamic GABAergic neurons are part of the GnRH pulse and surge generator

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Effects of extracts from Cimicifuga racemosa on gonadotropin release in menopausal women and ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

A systematic review of the skeletal effects of estrogen therapy in postmenopausal women. II. An assessment of treatment effects

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Estrogen regulates the rate of bone turnover but bone balance in ovariectomized rats is modulated by prevailing mechanical strain

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

Calvariae from fetal mice with a disrupted Igf1 gene have reduced rates of collagen synthesis but maintain responsiveness to glucocorticoids.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

In vitro effects of the Cimicifuga racemosa extract BNO 1055.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900344-4

7 January 2021

10.1016/S0378-5122(02)00344-4

Identifiers

DOI

1 reference

6 August 2017

1 reference